Cue Biopharma, Inc. (CUE)
NASDAQ
Cue Biopharma, Inc. annual/quarterly long term debt history from 2022 to 2023. Long term debt refers to financial obligations that are due more than one year in the future.
- Cue Biopharma, Inc. long term debt for the quarter ending December 31, 2023 were 4.0M, a 50.00% decrease year-over-year.
- Cue Biopharma, Inc. long term debt for 2023 were 4.0M, a 50.00% decrease from 2022.
- Cue Biopharma, Inc. long term debt for 2022 were 8.0M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Cue Biopharma, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2023 | $4 |
| 2022 | $8 |
| Cue Biopharma, Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2023-12-31 | $4 |
| 2022-12-31 | $8 |
Cue Biopharma, Inc. Long Term Debt — FAQ
Cue Biopharma, Inc. (CUE) long term debt over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CUE's long term debt history?
The chart and table above show Cue Biopharma, Inc.'s long term debt by year and by quarter, including the growth rate.